PRL Media/news, page-1870

if I had a dollar for every time I heard " scoping study shouldn't be too long" it would have me a a major shareholder.

been waiting for it since August.

I still can't help but feel a somewhat positive scoping study is already priced in to the 15-19 cent ceiling. there will also be some waiting to sell into a positive scoping study.

unless there's a knockout announcement of some sort, I don't think scoping study alone will deliver significant gains.

happy to be wrong